Skip to main content

What the FDA labels say about taking them together

Methotrexate and pivmecillinam

Pivmecillinam's FDA label of October 10, 2025 names methotrexate in its drug interactions section; the methotrexate labels PlainMeds reads (4) do not name pivmecillinam. The pivmecillinam label: “Clearance of methotrexate from the body can be reduced by concurrent use of drugs in the penicillin class, including PIVYA. Where possible, consider alternative therapy.”

Check it at the source: the methotrexate FDA label on DailyMed (effective May 27, 2026, Accord Healthcare Inc.); the pivmecillinam FDA label on DailyMed (effective October 10, 2025, Alembic Pharmaceuticals Inc.).

What does the methotrexate label say about pivmecillinam?

Methotrexate's label (effective May 27, 2026) and its 3 other brand-application labels do not name pivmecillinam in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methotrexate), Accord Healthcare Inc., effective May 27, 2026 (SPL set 874c7f43-a3be-4236-89cc-24c44e3c5813), via openFDA; the full label on DailyMed

What does the pivmecillinam label say about methotrexate?

Pivmecillinam label, drug interactions

Clearance of methotrexate from the body can be reduced by concurrent use of drugs in the penicillin class, including PIVYA. Where possible, consider alternative therapy.

Source: FDA drug label (PIVYA), Alembic Pharmaceuticals Inc., effective October 10, 2025 (SPL set 440a5f17-ab11-0fc8-e063-6394a90a58e9), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

29Methotrexate generic labelers
0Pivmecillinam generic labelers
MethotrexatePivmecillinam
Labeled forRheumatoid arthritis, Psoriasis, Leukemia, lymphoma and myeloma, Breast cancerUrinary tract infections
Boxed warningYesNo
Pharmacy cost (NADAC)$0.158 per tablet 2.5 mg tabletn/a
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?